BRAIN+ A/S |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.07 DKK | -6.42% |
|
-12.50% | -63.92% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Brain+ A/S is a Denmark-based software company primarily engaged in developing medical software. The Company focuses on the development of digital treatment for dementia and Alzheimerâs disease by digital therapeutics. The Companyâs main activities include the development of Cognitive Stimulation Therapy for the treatment of dementia, Computerized Cognitive Training for the treatment of earlier stages of Alzheimerâs and Starry Night memory test for early detection and monitoring of Alzheimerâs. It offers a product called Digital CST assistant giving access to Cognitive Stimulation Therapy sessions, available in Danish.
Sector
Software
| 1st Jan change | Capi. | |
|---|---|---|
| -63.92% | 918K | |
| +17.69% | 3,289B | |
| +14.62% | 90.43B | |
| +14.59% | 85.57B | |
| +37.27% | 52.49B | |
| -19.18% | 50.25B | |
| +32.93% | 46.79B | |
| +83.75% | 42.74B | |
| -32.70% | 41.67B | |
| -1.24% | 27.82B |
- Stock Market
- Equities
- BRAINP Stock
- News Brain+ A/S
- Brain+ to Initiate Feasibility Studies of Digital Dementia Therapy Support Product in Q4
